Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

VASTO

Financiado

VAScularised Tumour Organoids on a chip with human placenta vessels as a preclin...

VAScularised Tumour Organoids on a chip with human placenta vessels as a preclinical model for anticancer therapies. VASTO Proof of Concept aims to develop and test an innovative microfluidic-based platform, which allows to evaluate the efficacy of different cell immunotherapy strategies against solid tumours. For this aim, we propose to microf... ver más

30/04/2025

UNIZAR

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

UNIVERSIDAD DE ZARAGOZA. OFICINA DE TRANSFERE... No se ha especificado una descripción o un objeto social para esta compañía.

Sin perfil tecnológico

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-08-21

ERC-2023-POC: ERC PROOF OF CONCEPT GRANTS Objective:Objectives:The ERC Proof of Concept Grants aim at facilitating exploration of the commerci...

I+D

Cerrada hace 1 año

0% 100% 100%

2 Participantes

UNIZAR

130.00K€ | Lider

FUNDACIÓN INSTITUTO DE INVES...

20.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PLEC2022-009217 ENCAPSULACIÓN DE CÉLULAS CART EN SISTEMAS POROSOS NANOESTRUC... 357K€ Cerrado

PID2021-129115OB-I00 HERRAMIENTAS MICROFLUIDICAS BASADAS EN HIDROGELES PARA INVES... 151K€ Cerrado

PCI2020-111993 MOORE4MEDICAL: ACELERANDO LA INNOVACION EN DISPOSITIVOS MEDI... 63K€ Cerrado

PID2021-126277OB-I00 DESARROLLO DE NUEVOS AGENTES ANTICANCER MULTIDIANA CON POTEN... 97K€ Cerrado

FJC2021-048046-I Microfluidica aplicada a modelos tumorales 65K€ Cerrado

CPP2021-008871 Phase I clinical trial of a new antitumor therapy based on n... 2K€ Cerrado

Duración del proyecto: 20 meses Fecha Inicio: 2023-08-21
Fecha Fin: 2025-04-30

Líder del proyecto

UNIVERSIDAD DE ZARAGOZA. OFICINA DE TRANSFERE... No se ha especificado una descripción o un objeto social para esta compañía.

Sin perfil tecnológico

Presupuesto del proyecto 150K€

Descripción del proyecto VASTO Proof of Concept aims to develop and test an innovative microfluidic-based platform, which allows to evaluate the efficacy of different cell immunotherapy strategies against solid tumours. For this aim, we propose to microfabricate 3D solid tumour organoids with an aberrant microvascular network provided from the explant of human vessels. Although there are other different vessel-on-a-chip and/or microvascular network formation approaches that use in vitro cell monolayers, we are not aware of any solution covering human ex vivo blood vessel platform as it is proposed here. Therefore, we aim to recreate the existent mechano-chemical barriers characteristics of the tumour microenvironment in solid tumours with this novel ex vivo platform. With this technology, we can define a method to evaluate the efficacy of different immunotherapy-based strategies. Specifically, we focus on studying the effectivity of different Chimeric Antigen Receptor (CAR)-T cell therapies in solid tumours. Hence, the development of VASTO harbours the interest of CAR-T manufacturers to test these cell therapies against solid tumours. We will be able to asses CAR-T cell vascular extravasation, penetration into solid tumours and the CAR-T efficiency for tumour elimination. In addition to its applicability to liver cancer, the acquired knowledge in VASTO also could be extrapolated to any other kind tumours, but also in the development of an ex vivo platform for research in regenerative processes, by incorporating organoids from healthy donors, instead of malignant cells, and promoting functional vasculature, instead of aberrant one. Therefore, this human ex vivo platform will launch a new product to the market very attractive for clinical labs and companies, reducing animal experiments and providing a more reliable alternative for testing different therapies against tumours and approaching a more personalized patient-like model.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores